Project
GSE58827: Dynamics of the Mouse Liver
Navigation
Downloads
Results for Ebf3
Z-value: 2.00
Motif logo
Transcription factors associated with Ebf3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
Ebf3
|
ENSMUSG00000010476.7 | early B cell factor 3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Ebf3 | mm10_v2_chr7_-_137314394_137314445 | 0.27 | 1.1e-01 | Click! |
Activity profile of Ebf3 motif
Sorted Z-values of Ebf3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chrX_-_7967817 | 22.67 |
ENSMUST00000033502.7
|
Gata1
|
GATA binding protein 1 |
| chr2_-_28621932 | 22.33 |
ENSMUST00000028156.7
ENSMUST00000164290.1 |
Gfi1b
|
growth factor independent 1B |
| chr11_-_102365111 | 21.96 |
ENSMUST00000006749.9
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
| chr12_+_109453455 | 19.91 |
ENSMUST00000109844.4
ENSMUST00000109842.2 ENSMUST00000109843.1 ENSMUST00000109846.4 ENSMUST00000173539.1 ENSMUST00000109841.2 |
Dlk1
|
delta-like 1 homolog (Drosophila) |
| chr17_-_48451510 | 14.63 |
ENSMUST00000024794.5
|
Tspo2
|
translocator protein 2 |
| chr11_-_53480178 | 13.12 |
ENSMUST00000104955.2
|
Sowaha
|
sosondowah ankyrin repeat domain family member A |
| chr2_-_28084877 | 12.05 |
ENSMUST00000028179.8
ENSMUST00000117486.1 ENSMUST00000135472.1 |
Fcnb
|
ficolin B |
| chr11_+_95010277 | 12.04 |
ENSMUST00000124735.1
|
Samd14
|
sterile alpha motif domain containing 14 |
| chr14_-_60086832 | 11.88 |
ENSMUST00000080368.5
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
| chr15_+_80623499 | 11.22 |
ENSMUST00000043149.7
|
Grap2
|
GRB2-related adaptor protein 2 |
| chr14_-_69503316 | 10.94 |
ENSMUST00000179116.2
|
Gm21464
|
predicted gene, 21464 |
| chr10_-_128401218 | 10.14 |
ENSMUST00000042666.5
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
| chr11_-_116076986 | 9.68 |
ENSMUST00000153408.1
|
Unc13d
|
unc-13 homolog D (C. elegans) |
| chr19_-_45816007 | 9.36 |
ENSMUST00000079431.3
ENSMUST00000026247.6 ENSMUST00000162528.2 |
Kcnip2
|
Kv channel-interacting protein 2 |
| chr11_+_115877497 | 9.32 |
ENSMUST00000144032.1
|
Myo15b
|
myosin XVB |
| chr9_-_44288131 | 9.28 |
ENSMUST00000160384.1
|
Abcg4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
| chr11_+_115900125 | 9.19 |
ENSMUST00000142089.1
ENSMUST00000131566.1 |
Smim5
|
small integral membrane protein 5 |
| chr7_+_142442330 | 8.83 |
ENSMUST00000149529.1
|
Tnni2
|
troponin I, skeletal, fast 2 |
| chr17_+_48359891 | 8.69 |
ENSMUST00000024792.6
|
Treml1
|
triggering receptor expressed on myeloid cells-like 1 |
| chr1_+_75400070 | 8.33 |
ENSMUST00000113589.1
|
Speg
|
SPEG complex locus |
| chr14_-_60087347 | 7.96 |
ENSMUST00000149414.1
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
| chr1_-_193370260 | 7.78 |
ENSMUST00000016323.4
|
Camk1g
|
calcium/calmodulin-dependent protein kinase I gamma |
| chr4_+_120666562 | 7.72 |
ENSMUST00000094814.4
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
| chrX_+_7822289 | 7.51 |
ENSMUST00000009875.4
|
Kcnd1
|
potassium voltage-gated channel, Shal-related family, member 1 |
| chr11_+_87755567 | 7.48 |
ENSMUST00000123700.1
|
A430104N18Rik
|
RIKEN cDNA A430104N18 gene |
| chr6_-_86669136 | 7.07 |
ENSMUST00000001184.7
|
Mxd1
|
MAX dimerization protein 1 |
| chr7_-_126414855 | 7.01 |
ENSMUST00000032968.5
|
Cd19
|
CD19 antigen |
| chr7_+_24897381 | 6.99 |
ENSMUST00000003469.7
|
Cd79a
|
CD79A antigen (immunoglobulin-associated alpha) |
| chr7_+_142441808 | 6.75 |
ENSMUST00000105971.1
ENSMUST00000145287.1 |
Tnni2
|
troponin I, skeletal, fast 2 |
| chr7_+_19411086 | 6.60 |
ENSMUST00000003643.1
|
Ckm
|
creatine kinase, muscle |
| chr16_-_76022266 | 6.48 |
ENSMUST00000114240.1
|
Samsn1
|
SAM domain, SH3 domain and nuclear localization signals, 1 |
| chr1_-_193370225 | 6.44 |
ENSMUST00000169907.1
|
Camk1g
|
calcium/calmodulin-dependent protein kinase I gamma |
| chr10_-_60219260 | 6.22 |
ENSMUST00000135158.2
|
Chst3
|
carbohydrate (chondroitin 6/keratan) sulfotransferase 3 |
| chr7_+_28982832 | 6.21 |
ENSMUST00000085835.6
|
Map4k1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
| chr11_+_77009265 | 6.19 |
ENSMUST00000129572.2
|
Slc6a4
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
| chr12_-_109068173 | 6.18 |
ENSMUST00000073156.7
|
Begain
|
brain-enriched guanylate kinase-associated |
| chr2_+_25372315 | 5.89 |
ENSMUST00000028329.6
ENSMUST00000114293.2 ENSMUST00000100323.2 |
Sapcd2
|
suppressor APC domain containing 2 |
| chr1_+_74278550 | 5.77 |
ENSMUST00000077985.3
|
Gpbar1
|
G protein-coupled bile acid receptor 1 |
| chrX_+_48146436 | 5.73 |
ENSMUST00000033427.6
|
Sash3
|
SAM and SH3 domain containing 3 |
| chr15_-_66812593 | 5.73 |
ENSMUST00000100572.3
|
Sla
|
src-like adaptor |
| chr9_+_45403138 | 5.66 |
ENSMUST00000041005.5
|
Fxyd2
|
FXYD domain-containing ion transport regulator 2 |
| chr11_-_98053415 | 5.64 |
ENSMUST00000017544.2
|
Stac2
|
SH3 and cysteine rich domain 2 |
| chr7_-_25615874 | 5.42 |
ENSMUST00000098663.1
|
Gm7092
|
predicted gene 7092 |
| chr11_-_11808923 | 5.32 |
ENSMUST00000109664.1
ENSMUST00000150714.1 ENSMUST00000047689.4 ENSMUST00000171938.1 ENSMUST00000171080.1 |
Fignl1
|
fidgetin-like 1 |
| chr3_-_100489324 | 5.27 |
ENSMUST00000061455.8
|
Fam46c
|
family with sequence similarity 46, member C |
| chr2_-_126499839 | 5.19 |
ENSMUST00000040128.5
|
Atp8b4
|
ATPase, class I, type 8B, member 4 |
| chr6_+_30639218 | 5.18 |
ENSMUST00000031806.9
|
Cpa1
|
carboxypeptidase A1, pancreatic |
| chr2_-_118703963 | 5.18 |
ENSMUST00000104937.1
|
Ankrd63
|
ankyrin repeat domain 63 |
| chr4_+_133240778 | 5.12 |
ENSMUST00000030677.6
|
Map3k6
|
mitogen-activated protein kinase kinase kinase 6 |
| chr7_-_142699510 | 5.05 |
ENSMUST00000105934.1
|
Ins2
|
insulin II |
| chr11_-_94474088 | 4.95 |
ENSMUST00000107786.1
ENSMUST00000107791.1 ENSMUST00000103166.2 ENSMUST00000107792.1 ENSMUST00000100561.3 ENSMUST00000107793.1 ENSMUST00000107788.1 ENSMUST00000107790.1 ENSMUST00000107789.1 ENSMUST00000107785.1 ENSMUST00000021234.8 |
Cacna1g
|
calcium channel, voltage-dependent, T type, alpha 1G subunit |
| chr5_+_30711564 | 4.94 |
ENSMUST00000114729.1
|
Dpysl5
|
dihydropyrimidinase-like 5 |
| chr2_-_13491900 | 4.68 |
ENSMUST00000091436.5
|
Cubn
|
cubilin (intrinsic factor-cobalamin receptor) |
| chr1_-_136234113 | 4.67 |
ENSMUST00000120339.1
ENSMUST00000048668.8 |
5730559C18Rik
|
RIKEN cDNA 5730559C18 gene |
| chr10_-_88146867 | 4.65 |
ENSMUST00000164121.1
ENSMUST00000164803.1 ENSMUST00000168163.1 ENSMUST00000048518.9 |
Parpbp
|
PARP1 binding protein |
| chr7_-_25297866 | 4.64 |
ENSMUST00000148150.1
ENSMUST00000155118.1 |
Pafah1b3
|
platelet-activating factor acetylhydrolase, isoform 1b, subunit 3 |
| chr19_+_58728887 | 4.63 |
ENSMUST00000048644.5
|
Pnliprp1
|
pancreatic lipase related protein 1 |
| chr15_+_78244781 | 4.57 |
ENSMUST00000096357.5
ENSMUST00000133618.1 |
Ncf4
|
neutrophil cytosolic factor 4 |
| chr12_-_114416895 | 4.52 |
ENSMUST00000179796.1
|
Ighv6-5
|
immunoglobulin heavy variable V6-5 |
| chr5_+_136967859 | 4.46 |
ENSMUST00000001790.5
|
Cldn15
|
claudin 15 |
| chrX_-_162964557 | 4.45 |
ENSMUST00000038769.2
|
S100g
|
S100 calcium binding protein G |
| chr7_+_128062657 | 4.44 |
ENSMUST00000120355.1
ENSMUST00000106240.2 ENSMUST00000098015.3 |
Itgam
|
integrin alpha M |
| chr9_+_95637601 | 4.44 |
ENSMUST00000015498.8
|
Pcolce2
|
procollagen C-endopeptidase enhancer 2 |
| chr11_-_102946688 | 4.43 |
ENSMUST00000057849.5
|
C1ql1
|
complement component 1, q subcomponent-like 1 |
| chr4_+_43957401 | 4.34 |
ENSMUST00000030202.7
|
Glipr2
|
GLI pathogenesis-related 2 |
| chr13_-_22009730 | 4.33 |
ENSMUST00000006341.2
|
Prss16
|
protease, serine, 16 (thymus) |
| chr13_+_55399648 | 4.32 |
ENSMUST00000057167.7
|
Slc34a1
|
solute carrier family 34 (sodium phosphate), member 1 |
| chr8_-_105851981 | 4.30 |
ENSMUST00000040776.4
|
Cenpt
|
centromere protein T |
| chr5_+_37245792 | 4.29 |
ENSMUST00000031004.7
|
Crmp1
|
collapsin response mediator protein 1 |
| chrX_-_150813637 | 4.20 |
ENSMUST00000112700.1
|
Maged2
|
melanoma antigen, family D, 2 |
| chr13_+_108214389 | 4.15 |
ENSMUST00000022207.8
|
Elovl7
|
ELOVL family member 7, elongation of long chain fatty acids (yeast) |
| chr7_+_128062635 | 4.08 |
ENSMUST00000064821.7
ENSMUST00000106242.3 |
Itgam
|
integrin alpha M |
| chr1_-_171281181 | 4.08 |
ENSMUST00000073120.4
|
Ppox
|
protoporphyrinogen oxidase |
| chr15_+_78913916 | 4.01 |
ENSMUST00000089378.4
|
Pdxp
|
pyridoxal (pyridoxine, vitamin B6) phosphatase |
| chr2_+_154548888 | 4.00 |
ENSMUST00000045116.4
ENSMUST00000109709.3 |
1700003F12Rik
|
RIKEN cDNA 1700003F12 gene |
| chr11_+_96929367 | 3.92 |
ENSMUST00000062172.5
|
Prr15l
|
proline rich 15-like |
| chr4_-_148130678 | 3.87 |
ENSMUST00000030862.4
|
Draxin
|
dorsal inhibitory axon guidance protein |
| chr11_-_72411695 | 3.87 |
ENSMUST00000108500.1
ENSMUST00000050226.6 |
Smtnl2
|
smoothelin-like 2 |
| chr8_+_70493156 | 3.87 |
ENSMUST00000008032.7
|
Crlf1
|
cytokine receptor-like factor 1 |
| chr14_-_62292959 | 3.84 |
ENSMUST00000063169.8
|
Dleu7
|
deleted in lymphocytic leukemia, 7 |
| chrX_+_75382384 | 3.83 |
ENSMUST00000033541.4
|
Fundc2
|
FUN14 domain containing 2 |
| chr4_-_149676043 | 3.83 |
ENSMUST00000118704.1
|
Pik3cd
|
phosphatidylinositol 3-kinase catalytic delta polypeptide |
| chr7_+_80186835 | 3.68 |
ENSMUST00000107383.1
ENSMUST00000032754.7 |
Sema4b
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
| chr16_+_32608973 | 3.68 |
ENSMUST00000120680.1
|
Tfrc
|
transferrin receptor |
| chr5_+_30711849 | 3.62 |
ENSMUST00000088081.4
ENSMUST00000101442.3 |
Dpysl5
|
dihydropyrimidinase-like 5 |
| chr4_+_43957678 | 3.62 |
ENSMUST00000107855.1
|
Glipr2
|
GLI pathogenesis-related 2 |
| chr4_+_138725282 | 3.52 |
ENSMUST00000030530.4
ENSMUST00000124660.1 |
Pla2g2c
|
phospholipase A2, group IIC |
| chr11_-_59035064 | 3.40 |
ENSMUST00000138587.1
|
Obscn
|
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF |
| chr14_+_54476100 | 3.39 |
ENSMUST00000164766.1
ENSMUST00000164697.1 |
Rem2
|
rad and gem related GTP binding protein 2 |
| chr16_+_32608920 | 3.37 |
ENSMUST00000023486.8
|
Tfrc
|
transferrin receptor |
| chr11_+_63128973 | 3.35 |
ENSMUST00000108702.1
|
Pmp22
|
peripheral myelin protein 22 |
| chr6_+_120093348 | 3.34 |
ENSMUST00000112711.2
|
Ninj2
|
ninjurin 2 |
| chr7_-_4546567 | 3.33 |
ENSMUST00000065957.5
|
Syt5
|
synaptotagmin V |
| chr7_+_128062698 | 3.32 |
ENSMUST00000119696.1
|
Itgam
|
integrin alpha M |
| chr17_-_6782775 | 3.28 |
ENSMUST00000064234.6
|
Ezr
|
ezrin |
| chr7_-_3677509 | 3.21 |
ENSMUST00000038743.8
|
Tmc4
|
transmembrane channel-like gene family 4 |
| chr8_+_84970068 | 3.17 |
ENSMUST00000164807.1
|
Prdx2
|
peroxiredoxin 2 |
| chr15_+_99224976 | 3.08 |
ENSMUST00000041415.3
|
Kcnh3
|
potassium voltage-gated channel, subfamily H (eag-related), member 3 |
| chr4_-_93335510 | 3.07 |
ENSMUST00000066774.4
|
Tusc1
|
tumor suppressor candidate 1 |
| chr17_+_47672720 | 3.06 |
ENSMUST00000152724.1
|
Usp49
|
ubiquitin specific peptidase 49 |
| chr4_-_129121699 | 3.01 |
ENSMUST00000135763.1
ENSMUST00000149763.1 ENSMUST00000164649.1 |
Hpca
|
hippocalcin |
| chr11_+_16951371 | 2.98 |
ENSMUST00000109635.1
ENSMUST00000061327.1 |
Fbxo48
|
F-box protein 48 |
| chr5_+_137629169 | 2.96 |
ENSMUST00000176667.1
|
Lrch4
|
leucine-rich repeats and calponin homology (CH) domain containing 4 |
| chr11_+_96929260 | 2.95 |
ENSMUST00000054311.5
ENSMUST00000107636.3 |
Prr15l
|
proline rich 15-like |
| chr2_+_130295148 | 2.91 |
ENSMUST00000110288.2
|
Ebf4
|
early B cell factor 4 |
| chr8_+_119700009 | 2.90 |
ENSMUST00000095171.3
|
Atp2c2
|
ATPase, Ca++ transporting, type 2C, member 2 |
| chr1_+_135840857 | 2.89 |
ENSMUST00000179863.1
ENSMUST00000112086.2 ENSMUST00000112087.2 ENSMUST00000112085.2 ENSMUST00000178854.1 ENSMUST00000027671.5 |
Tnnt2
|
troponin T2, cardiac |
| chr11_+_101316200 | 2.84 |
ENSMUST00000142640.1
ENSMUST00000019470.7 |
Psme3
|
proteaseome (prosome, macropain) activator subunit 3 (PA28 gamma, Ki) |
| chr18_+_34624621 | 2.82 |
ENSMUST00000167161.1
|
Kif20a
|
kinesin family member 20A |
| chr11_+_3989924 | 2.81 |
ENSMUST00000109981.1
|
Gal3st1
|
galactose-3-O-sulfotransferase 1 |
| chr7_-_45920830 | 2.78 |
ENSMUST00000164119.1
|
Emp3
|
epithelial membrane protein 3 |
| chr11_+_101316917 | 2.74 |
ENSMUST00000151385.1
|
Psme3
|
proteaseome (prosome, macropain) activator subunit 3 (PA28 gamma, Ki) |
| chr10_+_116143881 | 2.70 |
ENSMUST00000105271.2
|
Ptprr
|
protein tyrosine phosphatase, receptor type, R |
| chr9_-_32542861 | 2.70 |
ENSMUST00000183767.1
|
Fli1
|
Friend leukemia integration 1 |
| chr10_+_60346851 | 2.67 |
ENSMUST00000020301.7
ENSMUST00000105460.1 ENSMUST00000170507.1 |
4632428N05Rik
|
RIKEN cDNA 4632428N05 gene |
| chr15_+_79516396 | 2.67 |
ENSMUST00000010974.7
|
Kdelr3
|
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 |
| chr4_+_141147911 | 2.66 |
ENSMUST00000030757.9
|
Fbxo42
|
F-box protein 42 |
| chr2_-_113829069 | 2.64 |
ENSMUST00000024005.7
|
Scg5
|
secretogranin V |
| chr9_-_37433138 | 2.64 |
ENSMUST00000115038.1
|
Robo3
|
roundabout homolog 3 (Drosophila) |
| chr17_+_47726834 | 2.63 |
ENSMUST00000024782.5
ENSMUST00000144955.1 |
Pgc
|
progastricsin (pepsinogen C) |
| chr9_+_103305156 | 2.61 |
ENSMUST00000035164.3
|
Topbp1
|
topoisomerase (DNA) II binding protein 1 |
| chr9_-_30922452 | 2.61 |
ENSMUST00000065112.6
|
Adamts15
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 15 |
| chr2_+_26319741 | 2.61 |
ENSMUST00000066889.6
|
Gpsm1
|
G-protein signalling modulator 1 (AGS3-like, C. elegans) |
| chr11_-_96977660 | 2.57 |
ENSMUST00000107626.1
ENSMUST00000107624.1 |
Sp2
|
Sp2 transcription factor |
| chr17_-_50094277 | 2.56 |
ENSMUST00000113195.1
|
Rftn1
|
raftlin lipid raft linker 1 |
| chr2_+_30441831 | 2.54 |
ENSMUST00000131476.1
|
Ppp2r4
|
protein phosphatase 2A, regulatory subunit B (PR 53) |
| chr9_+_30942541 | 2.50 |
ENSMUST00000068135.6
|
Adamts8
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 8 |
| chr6_-_69284319 | 2.48 |
ENSMUST00000103349.1
|
Igkv4-69
|
immunoglobulin kappa variable 4-69 |
| chr19_+_45149833 | 2.41 |
ENSMUST00000026236.9
|
Tlx1
|
T cell leukemia, homeobox 1 |
| chr6_-_73221625 | 2.39 |
ENSMUST00000064948.6
ENSMUST00000114040.1 |
Dnah6
|
dynein, axonemal, heavy chain 6 |
| chr14_-_34588654 | 2.38 |
ENSMUST00000022328.6
ENSMUST00000064098.6 ENSMUST00000022327.5 ENSMUST00000022330.7 |
Ldb3
|
LIM domain binding 3 |
| chr4_-_141416002 | 2.37 |
ENSMUST00000006378.2
ENSMUST00000105788.1 |
Clcnkb
|
chloride channel Kb |
| chr2_-_153241402 | 2.35 |
ENSMUST00000056924.7
|
Plagl2
|
pleiomorphic adenoma gene-like 2 |
| chr4_-_131821516 | 2.31 |
ENSMUST00000097860.2
|
Ptpru
|
protein tyrosine phosphatase, receptor type, U |
| chr17_+_23679363 | 2.30 |
ENSMUST00000024699.2
|
Cldn6
|
claudin 6 |
| chr2_+_125068118 | 2.27 |
ENSMUST00000070353.3
|
Slc24a5
|
solute carrier family 24, member 5 |
| chr11_+_75650501 | 2.24 |
ENSMUST00000102505.3
|
Myo1c
|
myosin IC |
| chr7_-_25297967 | 2.23 |
ENSMUST00000005583.5
|
Pafah1b3
|
platelet-activating factor acetylhydrolase, isoform 1b, subunit 3 |
| chr5_-_147400352 | 2.17 |
ENSMUST00000049324.8
ENSMUST00000176456.1 ENSMUST00000110549.1 |
Flt3
|
FMS-like tyrosine kinase 3 |
| chr14_+_62292475 | 2.15 |
ENSMUST00000166879.1
|
Rnaseh2b
|
ribonuclease H2, subunit B |
| chr6_-_91116785 | 2.13 |
ENSMUST00000113509.1
ENSMUST00000032179.7 |
Nup210
|
nucleoporin 210 |
| chr4_-_129121234 | 2.11 |
ENSMUST00000030572.3
|
Hpca
|
hippocalcin |
| chr14_+_67745229 | 2.09 |
ENSMUST00000111095.2
|
Gnrh1
|
gonadotropin releasing hormone 1 |
| chr11_-_3539228 | 2.08 |
ENSMUST00000075118.3
ENSMUST00000136243.1 ENSMUST00000170588.1 ENSMUST00000020721.8 |
Smtn
|
smoothelin |
| chr7_+_126781483 | 2.06 |
ENSMUST00000172352.1
ENSMUST00000094037.4 |
Tbx6
|
T-box 6 |
| chr4_+_130915949 | 2.06 |
ENSMUST00000030316.6
|
Laptm5
|
lysosomal-associated protein transmembrane 5 |
| chr4_+_154960915 | 2.03 |
ENSMUST00000049621.6
|
Hes5
|
hairy and enhancer of split 5 (Drosophila) |
| chr2_+_152754156 | 2.03 |
ENSMUST00000010020.5
|
Cox4i2
|
cytochrome c oxidase subunit IV isoform 2 |
| chr7_-_28372233 | 1.97 |
ENSMUST00000094644.4
|
Plekhg2
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
| chr17_-_80207299 | 1.93 |
ENSMUST00000063417.9
|
Srsf7
|
serine/arginine-rich splicing factor 7 |
| chr3_+_102735202 | 1.93 |
ENSMUST00000119902.1
|
Tspan2
|
tetraspanin 2 |
| chr14_+_62332068 | 1.91 |
ENSMUST00000022499.6
|
Rnaseh2b
|
ribonuclease H2, subunit B |
| chr7_+_49975228 | 1.88 |
ENSMUST00000107603.1
|
Nell1
|
NEL-like 1 |
| chr7_-_100932140 | 1.88 |
ENSMUST00000107032.1
|
Arhgef17
|
Rho guanine nucleotide exchange factor (GEF) 17 |
| chr3_+_108739658 | 1.88 |
ENSMUST00000133931.2
|
Aknad1
|
AKNA domain containing 1 |
| chr6_-_32588192 | 1.87 |
ENSMUST00000115096.2
|
Plxna4
|
plexin A4 |
| chr13_-_49309217 | 1.87 |
ENSMUST00000110087.2
|
Fgd3
|
FYVE, RhoGEF and PH domain containing 3 |
| chr11_-_69837781 | 1.86 |
ENSMUST00000108634.2
|
Nlgn2
|
neuroligin 2 |
| chr12_-_76962178 | 1.82 |
ENSMUST00000110395.3
ENSMUST00000082136.5 |
Max
|
Max protein |
| chrX_+_144688907 | 1.78 |
ENSMUST00000112843.1
|
Zcchc16
|
zinc finger, CCHC domain containing 16 |
| chr1_-_13127163 | 1.77 |
ENSMUST00000047577.6
|
Prdm14
|
PR domain containing 14 |
| chr5_-_123879992 | 1.73 |
ENSMUST00000164267.1
|
Gpr81
|
G protein-coupled receptor 81 |
| chr7_-_119479249 | 1.72 |
ENSMUST00000033263.4
|
Umod
|
uromodulin |
| chr14_-_54966570 | 1.72 |
ENSMUST00000124930.1
ENSMUST00000134256.1 ENSMUST00000081857.6 ENSMUST00000145322.1 |
Myh6
|
myosin, heavy polypeptide 6, cardiac muscle, alpha |
| chr5_+_129725063 | 1.72 |
ENSMUST00000086046.3
|
Gbas
|
glioblastoma amplified sequence |
| chr5_-_139130159 | 1.70 |
ENSMUST00000129851.1
|
Prkar1b
|
protein kinase, cAMP dependent regulatory, type I beta |
| chr7_-_45824750 | 1.65 |
ENSMUST00000071937.5
|
Kcnj14
|
potassium inwardly-rectifying channel, subfamily J, member 14 |
| chr2_+_178414512 | 1.64 |
ENSMUST00000094251.4
|
Fam217b
|
family with sequence similarity 217, member B |
| chr9_-_67043709 | 1.63 |
ENSMUST00000113689.1
ENSMUST00000113684.1 |
Tpm1
|
tropomyosin 1, alpha |
| chr6_-_116673790 | 1.62 |
ENSMUST00000035842.4
|
Rassf4
|
Ras association (RalGDS/AF-6) domain family member 4 |
| chr5_-_139129662 | 1.60 |
ENSMUST00000026973.7
|
Prkar1b
|
protein kinase, cAMP dependent regulatory, type I beta |
| chr4_+_137681663 | 1.57 |
ENSMUST00000047243.5
|
Rap1gap
|
Rap1 GTPase-activating protein |
| chr17_+_35866056 | 1.56 |
ENSMUST00000122899.1
|
Ppp1r18
|
protein phosphatase 1, regulatory subunit 18 |
| chr7_+_4690760 | 1.54 |
ENSMUST00000048248.7
|
Brsk1
|
BR serine/threonine kinase 1 |
| chr17_+_83706137 | 1.54 |
ENSMUST00000112350.1
ENSMUST00000112349.2 ENSMUST00000112352.3 |
Mta3
|
metastasis associated 3 |
| chr9_+_121760000 | 1.52 |
ENSMUST00000093772.3
|
Zfp651
|
zinc finger protein 651 |
| chr3_+_59006978 | 1.51 |
ENSMUST00000040325.7
ENSMUST00000164225.1 ENSMUST00000040846.8 ENSMUST00000029393.8 |
Med12l
|
mediator of RNA polymerase II transcription, subunit 12 homolog (yeast)-like |
| chr15_+_76797628 | 1.51 |
ENSMUST00000165535.2
|
Gm17271
|
predicted gene, 17271 |
| chr11_-_29825649 | 1.51 |
ENSMUST00000104962.1
|
4931440F15Rik
|
RIKEN cDNA 4931440F15 gene |
| chr3_+_100489508 | 1.50 |
ENSMUST00000122898.1
|
Gm12474
|
predicted gene 12474 |
| chr11_+_70432627 | 1.50 |
ENSMUST00000084954.6
ENSMUST00000108568.3 ENSMUST00000079056.2 ENSMUST00000102564.4 ENSMUST00000124943.1 ENSMUST00000150076.1 ENSMUST00000102563.1 |
Arrb2
|
arrestin, beta 2 |
| chr8_+_71469186 | 1.47 |
ENSMUST00000124745.1
ENSMUST00000138892.1 ENSMUST00000147642.1 |
Dda1
|
DET1 and DDB1 associated 1 |
| chr10_-_127060163 | 1.46 |
ENSMUST00000040307.5
|
March9
|
membrane-associated ring finger (C3HC4) 9 |
| chr6_-_69631933 | 1.43 |
ENSMUST00000177697.1
|
Igkv4-54
|
immunoglobulin kappa chain variable 4-54 |
| chr7_-_45092198 | 1.41 |
ENSMUST00000140449.1
ENSMUST00000117546.1 ENSMUST00000019683.3 |
Rcn3
|
reticulocalbin 3, EF-hand calcium binding domain |
| chr1_+_172312367 | 1.40 |
ENSMUST00000039506.9
|
Igsf8
|
immunoglobulin superfamily, member 8 |
| chr8_-_71701796 | 1.40 |
ENSMUST00000034260.7
|
B3gnt3
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
| chr8_-_111082043 | 1.39 |
ENSMUST00000039597.7
|
Clec18a
|
C-type lectin domain family 18, member A |
| chr1_+_40805578 | 1.39 |
ENSMUST00000114765.2
|
Tmem182
|
transmembrane protein 182 |
| chr4_+_117835387 | 1.39 |
ENSMUST00000169885.1
|
Slc6a9
|
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
| chr17_+_83706170 | 1.38 |
ENSMUST00000067826.8
|
Mta3
|
metastasis associated 3 |
| chr5_+_137629112 | 1.38 |
ENSMUST00000031734.9
|
Lrch4
|
leucine-rich repeats and calponin homology (CH) domain containing 4 |
| chr5_+_103425181 | 1.37 |
ENSMUST00000048957.9
|
Ptpn13
|
protein tyrosine phosphatase, non-receptor type 13 |
| chr4_-_138725262 | 1.37 |
ENSMUST00000105811.2
|
Ubxn10
|
UBX domain protein 10 |
| chr7_-_127208423 | 1.36 |
ENSMUST00000120705.1
|
Tbc1d10b
|
TBC1 domain family, member 10b |
| chr1_+_89454769 | 1.34 |
ENSMUST00000027521.8
ENSMUST00000074945.5 |
Agap1
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
| chr4_-_116627478 | 1.34 |
ENSMUST00000081182.4
ENSMUST00000030457.5 |
Nasp
|
nuclear autoantigenic sperm protein (histone-binding) |
| chr7_-_142372210 | 1.34 |
ENSMUST00000084412.5
|
Ifitm10
|
interferon induced transmembrane protein 10 |
| chrX_-_38252398 | 1.33 |
ENSMUST00000089056.3
ENSMUST00000089054.4 ENSMUST00000066498.7 |
Tmem255a
|
transmembrane protein 255A |
| chr17_+_84626458 | 1.32 |
ENSMUST00000025101.8
|
Dync2li1
|
dynein cytoplasmic 2 light intermediate chain 1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of Ebf3
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.6 | 22.7 | GO:0030221 | basophil differentiation(GO:0030221) |
| 3.4 | 10.1 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 3.0 | 12.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 2.8 | 22.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
| 2.5 | 19.8 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 2.3 | 13.8 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 1.9 | 9.4 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 1.7 | 5.1 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 1.7 | 5.1 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) neuron projection maintenance(GO:1990535) |
| 1.5 | 6.2 | GO:0021941 | negative regulation of cerebellar granule cell precursor proliferation(GO:0021941) |
| 1.4 | 4.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 1.2 | 5.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 1.1 | 2.3 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 1.1 | 4.4 | GO:0061743 | motor learning(GO:0061743) |
| 1.1 | 3.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 1.1 | 9.7 | GO:0002432 | granuloma formation(GO:0002432) |
| 1.1 | 4.3 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.0 | 4.0 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
| 1.0 | 2.9 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.8 | 3.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.8 | 4.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.8 | 22.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.8 | 4.7 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.8 | 23.4 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.8 | 4.5 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
| 0.6 | 1.3 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
| 0.6 | 6.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.6 | 3.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.6 | 2.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
| 0.6 | 0.6 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.6 | 3.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.5 | 3.8 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.5 | 1.6 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.5 | 2.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
| 0.5 | 2.6 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.5 | 4.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.5 | 3.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.5 | 2.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.5 | 4.7 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.5 | 1.4 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.5 | 2.8 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.4 | 2.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.4 | 1.8 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) positive regulation of sperm motility(GO:1902093) |
| 0.4 | 1.6 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.4 | 7.0 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.4 | 2.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.4 | 3.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.4 | 2.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.4 | 1.9 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.4 | 1.1 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
| 0.4 | 1.1 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) |
| 0.3 | 1.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.3 | 1.7 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
| 0.3 | 6.1 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.3 | 5.8 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
| 0.3 | 3.2 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
| 0.3 | 0.6 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
| 0.3 | 2.8 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.3 | 4.7 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.3 | 4.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.3 | 5.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.3 | 0.6 | GO:0097117 | guanylate kinase-associated protein clustering(GO:0097117) |
| 0.3 | 5.6 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.3 | 4.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.3 | 1.4 | GO:0015692 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 0.3 | 2.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.2 | 1.5 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.2 | 1.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.2 | 2.9 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.2 | 2.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.2 | 1.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
| 0.2 | 10.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
| 0.2 | 2.4 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
| 0.2 | 1.9 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.2 | 1.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.2 | 15.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.2 | 0.7 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
| 0.2 | 10.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.2 | 9.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.2 | 0.9 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
| 0.2 | 0.8 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 | 2.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 8.0 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 | 0.7 | GO:0030049 | muscle filament sliding(GO:0030049) |
| 0.1 | 5.7 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
| 0.1 | 0.3 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 | 0.8 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.1 | 2.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 3.5 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 | 1.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.1 | 2.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 1.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 3.9 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.1 | 0.5 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.1 | 3.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
| 0.1 | 14.2 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
| 0.1 | 5.3 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.1 | 3.1 | GO:0045214 | sarcomere organization(GO:0045214) |
| 0.1 | 6.6 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
| 0.1 | 3.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.1 | 0.8 | GO:2000194 | regulation of female gonad development(GO:2000194) |
| 0.1 | 2.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.1 | 3.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 2.4 | GO:0048535 | lymph node development(GO:0048535) |
| 0.1 | 0.8 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 | 3.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 | 0.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.1 | 1.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.1 | 1.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 3.0 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 0.1 | 1.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
| 0.1 | 0.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 | 0.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.1 | 8.3 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
| 0.1 | 1.7 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.1 | 1.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 | 0.2 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
| 0.1 | 5.2 | GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway(GO:2001237) |
| 0.1 | 2.8 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
| 0.1 | 1.9 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 | 0.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 0.1 | 0.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
| 0.1 | 1.3 | GO:0043486 | histone exchange(GO:0043486) |
| 0.1 | 4.2 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.0 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 | 4.4 | GO:0043627 | response to estrogen(GO:0043627) |
| 0.0 | 2.4 | GO:0034394 | protein localization to cell surface(GO:0034394) |
| 0.0 | 3.8 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
| 0.0 | 1.0 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.0 | 5.2 | GO:0007030 | Golgi organization(GO:0007030) |
| 0.0 | 0.1 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
| 0.0 | 1.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.0 | 1.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.0 | 0.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 | 0.7 | GO:0042711 | maternal behavior(GO:0042711) |
| 0.0 | 0.1 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.0 | 4.9 | GO:0046777 | protein autophosphorylation(GO:0046777) |
| 0.0 | 0.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) response to linoleic acid(GO:0070543) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
| 0.0 | 6.2 | GO:0007411 | axon guidance(GO:0007411) |
| 0.0 | 0.4 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.0 | 0.8 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
| 0.0 | 0.7 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.0 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.0 | 3.3 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.0 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.0 | 0.6 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.0 | 0.9 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 | 0.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.0 | 1.5 | GO:0003341 | cilium movement(GO:0003341) |
| 0.0 | 1.0 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.0 | 0.6 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.0 | 2.0 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.0 | 0.3 | GO:0042246 | tissue regeneration(GO:0042246) |
| 0.0 | 0.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.0 | 0.4 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 5.6 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 1.0 | 18.5 | GO:0005861 | troponin complex(GO:0005861) |
| 1.0 | 7.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 1.0 | 3.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.9 | 4.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.9 | 4.4 | GO:0044301 | climbing fiber(GO:0044301) |
| 0.9 | 9.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.8 | 3.3 | GO:0044393 | microspike(GO:0044393) Schwann cell microvillus(GO:0097454) |
| 0.7 | 4.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.7 | 3.3 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.6 | 8.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.6 | 3.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.6 | 2.2 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.5 | 3.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.4 | 4.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.4 | 1.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.4 | 5.1 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.4 | 8.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.4 | 1.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
| 0.3 | 1.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
| 0.3 | 5.2 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
| 0.3 | 3.3 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.3 | 1.4 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.3 | 11.4 | GO:0008305 | integrin complex(GO:0008305) |
| 0.3 | 3.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.2 | 4.0 | GO:0070938 | contractile ring(GO:0070938) |
| 0.2 | 22.0 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.2 | 2.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.2 | 5.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.2 | 22.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.2 | 17.7 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.2 | 3.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.2 | 1.9 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.1 | 4.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.1 | 2.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.1 | 3.3 | GO:0043218 | compact myelin(GO:0043218) |
| 0.1 | 3.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.1 | 4.1 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
| 0.1 | 1.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.1 | 1.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.1 | 3.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 0.9 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.1 | 2.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.1 | 5.0 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 0.3 | GO:0071564 | SWI/SNF complex(GO:0016514) npBAF complex(GO:0071564) |
| 0.1 | 15.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.1 | 4.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 0.9 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.1 | 1.1 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.1 | 6.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.1 | 0.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 2.7 | GO:0030990 | intraciliary transport particle(GO:0030990) |
| 0.1 | 6.2 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 18.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 0.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.0 | 0.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.0 | 0.4 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.0 | 0.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.0 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 0.7 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 9.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 1.5 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 6.7 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 1.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.0 | 4.3 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 1.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.0 | 2.1 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.0 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.0 | 0.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.0 | 1.0 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 2.8 | GO:0005903 | brush border(GO:0005903) |
| 0.0 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.0 | 1.0 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 0.6 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.0 | 2.8 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 0.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.0 | 0.4 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 5.8 | GO:0000785 | chromatin(GO:0000785) |
| 0.0 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.4 | 16.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 2.3 | 9.3 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 2.3 | 6.9 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 2.1 | 6.2 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
| 1.7 | 11.8 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 1.6 | 15.6 | GO:0031014 | troponin T binding(GO:0031014) |
| 1.3 | 12.0 | GO:0033691 | sialic acid binding(GO:0033691) |
| 1.3 | 21.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 1.2 | 6.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 1.2 | 5.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 1.2 | 5.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 1.1 | 6.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 1.1 | 22.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 1.1 | 3.3 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 1.0 | 4.0 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
| 0.9 | 4.5 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.9 | 4.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.8 | 25.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.7 | 2.9 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.7 | 2.8 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
| 0.7 | 3.4 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.7 | 4.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.7 | 2.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.6 | 5.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.6 | 4.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.5 | 3.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.5 | 1.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.5 | 6.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.5 | 1.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.4 | 1.6 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.4 | 3.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.4 | 2.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.4 | 3.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.4 | 4.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.4 | 15.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.3 | 3.8 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 0.3 | 3.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.3 | 4.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.3 | 3.4 | GO:0031432 | titin binding(GO:0031432) |
| 0.3 | 3.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.3 | 1.4 | GO:0015100 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.3 | 9.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.3 | 17.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.3 | 2.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.3 | 0.8 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
| 0.3 | 4.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.2 | 1.7 | GO:0019864 | IgG binding(GO:0019864) |
| 0.2 | 2.9 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.2 | 5.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.2 | 13.8 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.2 | 3.3 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.2 | 1.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.2 | 0.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 0.2 | 5.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.2 | 5.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.2 | 4.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.2 | 2.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.2 | 2.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 0.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.1 | 0.6 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
| 0.1 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.1 | 9.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.1 | 1.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 1.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.1 | 0.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.1 | 2.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.1 | 3.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 4.4 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.1 | 2.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 2.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 1.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.1 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.1 | 0.8 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.1 | 1.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.1 | 4.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.1 | 1.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 3.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 15.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.1 | 1.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.1 | 2.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 2.0 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.7 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.1 | 0.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.1 | 0.2 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.1 | 10.1 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
| 0.1 | 3.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.1 | 1.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.1 | 10.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 5.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.0 | 2.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.0 | 1.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.0 | 0.1 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 0.0 | 1.0 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
| 0.0 | 0.6 | GO:0042166 | acetylcholine binding(GO:0042166) |
| 0.0 | 2.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.0 | 2.7 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.0 | 3.5 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
| 0.0 | 20.7 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.0 | 0.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 2.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 2.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 0.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.0 | 0.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.0 | 2.0 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.0 | 1.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.0 | 0.4 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.0 | 3.0 | GO:0042393 | histone binding(GO:0042393) |
| 0.0 | 0.8 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
| 0.0 | 1.0 | GO:0005178 | integrin binding(GO:0005178) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 17.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.5 | 3.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.4 | 26.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.4 | 12.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.3 | 32.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.3 | 1.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.2 | 2.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.2 | 7.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 3.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 11.7 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 1.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 4.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 1.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.1 | 8.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 2.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 3.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.1 | 2.6 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.1 | 12.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 2.8 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 1.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 1.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.0 | 1.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 3.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.0 | 3.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 6.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 1.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.0 | 0.8 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 4.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 1.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 0.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.0 | 1.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 13.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.7 | 33.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.5 | 19.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.4 | 20.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.4 | 11.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.4 | 9.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.4 | 15.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.4 | 4.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.3 | 6.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.3 | 6.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.3 | 2.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.2 | 4.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.2 | 28.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.2 | 7.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.2 | 26.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.2 | 4.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.2 | 6.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.1 | 6.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 11.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.1 | 3.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 1.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.1 | 1.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.1 | 3.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 9.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 2.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.1 | 3.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.1 | 3.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.1 | 2.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 1.3 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
| 0.1 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.0 | 1.9 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.0 | 2.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 0.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.0 | 3.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.0 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.0 | 0.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.0 | 2.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 0.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.0 | 1.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 1.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
| 0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.0 | 0.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.0 | 1.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 4.9 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.0 | 1.6 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
| 0.0 | 3.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 0.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 0.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |